Disseminating Drug Prescribing Information: The Cox-2 Inhibitors Withdrawals

Journal of the American Medical Informatics Association

Volumn 13, Issue 4, 2006, Pages 396-398

  Strayer, Scott M ^a   Slawson, David C ^a   Shaughnessy, Allen F ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; VALDECOXIB;

ARTICLE; AWARENESS; CALCULATION; CASE STUDY; DATA BASE; DRUG INDUSTRY; DRUG INFORMATION; DRUG MONITORING; DRUG WITHDRAWAL; ELECTRONICS; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEALTH CENTER; INFORMATION DISSEMINATION; INTERNET; MEDICAL INFORMATION SYSTEM; MEDICAL LITERATURE; PRESCRIPTION; PUBLICATION; QUALITATIVE ANALYSIS; SAMPLE; STATISTICAL ANALYSIS; TIME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CYCLOOXYGENASE 2 INHIBITORS; DATABASES, FACTUAL; DRUG APPROVAL; HUMANS; INFORMATION DISSEMINATION; INTERNET; ISOXAZOLES; LIBRARIES, DIGITAL; REFERENCE BOOKS, MEDICAL; SULFONAMIDES; TEXTBOOKS; UNITED STATES;

EID: 33745424813     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: 10.1197/jamia.M2045     Document Type: Article

References (14)

1. Alert for Healthcare Professionals Valdecoxib (marketed as Bextra). Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/valdecoxibHCP.htm. Accessed June 24, 2005.
2. Staffa J.A., Chang J., and Green L. Cerivastatin and reports of fatal rhabdomyolysis. NEJM 346 7 (2002) 539-540
3. Juni P., Nartey L., Reichenbach S., et al. Risk of cardiovascular events and rofecoxib. cumulative meta-analysis. Lancet 364 (2004) 2021-2029
4. Safety-based Drug Withdrawals, 1997-2001. Available at: http://www.fda.gov/fdac/features/2002/chrtWithdrawals.html. Accessed Feb 27, 2006.
5. Pirolli P., and Card S. Information Foraging. Psych Rev 106 (1999) 643-675
6. Shaughnessy A.F., and Slawson D.C. Are we providing doctors with the training and tools for lifelong learning?. BMJ (1999) 319-1280
7. Slawson D.C., and Shaughnessy A.F. Teaching Evidence-based Medicine. Should We Be Teaching Information Management Instead?. Acad Med 80 (2005) 685-689
8. Fineberg H.V. Clinical evaluation. how does it influence medical practice?. Bull Cancer 74 (1987) 333-346
9. Antman E.M., Lau J., Kupelnick B., et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 268 (1992) 240-248
10. Col N.F., McLaughlin J., Soumerai S.B., et al. The impact of clinical trials on the use of medications for acute myocardial infarction. Arch Int Med 156 (1996) 54-60
11. Majumdar S.R., McAlister F.A., and Soumerai S.B. Synergy between publication and promotion. Comparing adoption of new evidence in Canada and the United States. Am J Med 115 (2003) 467-472
12. Ely J.E. Analysis of questions asked by family doctors regarding patient care. BMJ 319 (1999) 358-361
13. Green M.L., Ciampi M.A., and Ellis P.J. Residents' Medical Information Needs in a Clinic. Are They Being Met?. Am J Med 109 (2000) 218-233
14. Lasser K.E., Allen P.D., Woolhandler S.J., Himmelstein D.U., Wolfe S.M., and Bor D.H. Timing of new black box warnings and withdrawals for prescription medications. JAMA 287 (2002) 2215-2220